External Body Weight Effects on Body Weight in Adults With Grade II and III Obesity
Launched by ESCOLES UNIVERSITARIES GIMBERNAT · Sep 25, 2024
Trial Information
Current as of August 20, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating how using external body weight can help adults with obesity, specifically those with a Body Mass Index (BMI) of 35 or higher. Obesity is a serious condition that can lead to health problems like heart disease and diabetes. In this study, researchers want to see if adding extra weight to the body can help regulate weight, body composition, and other health markers over a 12-week period. Participants will first go through a 4-week control phase without the external weight, followed by 4 weeks using the weight, and then a final 4 weeks of follow-up to monitor results.
To join the study, participants must be at least 18 years old and have a BMI of 35 or more. However, people with certain health issues that could interfere with the study, those who have experienced significant weight changes recently, or those with limited mobility won’t be eligible. If you participate, you can expect to engage in a structured program focused on weight management, with the aim to see if this new approach can effectively help in losing weight and improving overall health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age\>18 years
- • BMI (≥35)
- • Compliance at intervention delivery.
- Exclusion Criteria:
- • Chronic pathology that may hinder the performance of the intervention
- • Chronic pain
- • Regular consumption of pharmacology or supplementation that affects body weight
- • Inability to perform any physical activity or high risk of suffering adverse effects from the interventibariatric-metabolic surgery
- • Reduced mobility
- • Changes of 5kg or more in the last 3 months
- • Drastic changes in lifestyle habits in the last 3 months (physical activity, eating habits, nicotine or alcohol consumption)
- • Apparent risk of not being able to complete the study intervention (at the principal investigator\'s discretion)
- • Pregnancy
About Escoles Universitaries Gimbernat
Escoles Universitaries Gimbernat is a distinguished academic institution dedicated to advancing healthcare education and research. With a strong emphasis on fostering innovation and clinical excellence, the institution collaborates with various healthcare organizations to conduct rigorous clinical trials. Its commitment to upholding ethical standards and scientific integrity ensures that research findings contribute significantly to medical knowledge and improve patient outcomes. Through a multidisciplinary approach, Escoles Universitaries Gimbernat aims to enhance the quality of healthcare delivery and train the next generation of healthcare professionals.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sant Cugat Del Valles, Barcelona, Spain
Patients applied
Trial Officials
Maria Assumpta Caixàs Pedragós, PhD, MD
Principal Investigator
Consorci Sanitari Parc Taulí
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported